Home/Filings/4/0001415889-24-017511
4//SEC Filing

Marquet Magda 4

Accession 0001415889-24-017511

CIK 0001370053other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 8:17 PM ET

Size

7.3 KB

Accession

0001415889-24-017511

Insider Transaction Report

Form 4
Period: 2024-06-15
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-15+3,9003,900 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-06-153,9000 total
    Common Stock (3,900 underlying)
Footnotes (2)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001631486

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 8:17 PM ET
Size
7.3 KB